Boyle Scott N bought CCCC
February 14, 2026 · Form 4 insider transaction
Boyle Scott N bought 20,950 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,950
Price
$0.00
Total value
N/A
InsiderBoyle Scott N
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after306,070
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025.